Search results for NRU

Anti-CSDE1/NRU antibody, Abcam, AB96124

Anti-CSDE1/NRU antibody [EPR17413], Abcam, AB200663

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CSDE1/NRU antibody [EPR17414], Abcam, AB201688

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-CSDE1/NRU antibody [EPR17414], Abcam, AB319368

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

APC Anti-CSDE1/NRU antibody [EPR17414], Abcam, AB319220

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

P2RY4 Antibody (YA4067)(PBS only), MedChemexpress, HY-P84370A

P2RY4 Antibody (YA4067) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to P2RY4.

P2RY4 Antibody (YA4068)(PBS only), MedChemexpress, HY-P84371A

P2RY4 Antibody (YA4068) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to P2RY4.

P2RY4 Antibody (YA4067), MedChemexpress, HY-P84370

P2RY4 Antibody (YA4067) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to P2RY4.

P2RY4 Antibody (YA4068), MedChemexpress, HY-P84371

P2RY4 Antibody (YA4068) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to P2RY4.

P2Y4 antibody, Genetex, GTX13108